| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 377,544 | 392,273 | 357,048 | 368,520 | | Cost of Revenue | 129,333 | 132,325 | 134,033 | 125,552 | | | Gross Profit | 248,211 | 259,948 | 223,015 | 242,968 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,420 | 16,552 | 18,758 | 17,467 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 105,723 | 79,766 | 75,321 | 74,389 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 125,068 | 163,630 | 128,936 | 151,112 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,795 | (10,097) | (4,826) | 5,563 | | Earnings Before Interest And Taxes | 132,960 | (19,973) | 116,787 | 144,090 | | Interest Expense | 78,930 | 71,261 | 68,308 | 64,564 | | Income Before Tax | 54,030 | (91,234) | 48,479 | 79,526 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
| 14,053 | (9,967) | (14,440) | | | | Net Income From Continuing Ops | 54,030 | (91,234) | 48,479 | 79,526 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 54,030 | (91,234) | 48,479 | 79,526 | | Preferred Stock And Other Adjustments | (9,432) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $44,598 | ($91,234) | $48,479 | $79,526 |
|
0.45% Nasdaq 
0.20%
Income Statement
